Yan-Yan Wei1,2, Jing Fan2, Meng-Xuan Shan2, Dan-Dan Yin2, Li-Li Wang2, Wei Ye2, Wei Zhao2. 1. Department of Infectious Disease, The First Affiliated Hospital of Anhui Medical University Hefei 230022, Anhui, China. 2. Department of Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine Nanjing 210003, Jiangsu, China.
Abstract
BACKGROUND: Chronic HBV infection is a serious worldwide health problem that mainly causes liver cirrhosis and hepatocellular carcinoma (HCC). Few studies have explored how T cell exhaustion helps HBV avoid immune system attack and how to reverse that exhaustion. Recently, T cell immunoglobulin and immune receptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT) have been identified as coinhibitory receptors, similar to PD-1. This study explores the expression of TIGIT and the T cell function changes in patients with chronic HBV infection. RESULTS: In this study, we found that the expression of TIGIT on T cells increased significantly in patients with chronic HBV infection. High expression of TIGIT on T cells is associated with functional exhaustion. Importantly, this study demonstrates that blocking TIGIT can reverse T cell exhaustion and restore function in patients with chronic HBV infection. CONCLUSIONS: HBV induces T cell exhaustion by up-regulating the expression of TIGIT. Blocking the TIGIT/PVR signaling pathway can reverse T cell exhaustion, so this discovery provides an immunotherapy target to battle chronic HBV infection. AJTR
BACKGROUND: Chronic HBV infection is a serious worldwide health problem that mainly causes liver cirrhosis and hepatocellular carcinoma (HCC). Few studies have explored how T cell exhaustion helps HBV avoid immune system attack and how to reverse that exhaustion. Recently, T cell immunoglobulin and immune receptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT) have been identified as coinhibitory receptors, similar to PD-1. This study explores the expression of TIGIT and the T cell function changes in patients with chronic HBV infection. RESULTS: In this study, we found that the expression of TIGIT on T cells increased significantly in patients with chronic HBV infection. High expression of TIGIT on T cells is associated with functional exhaustion. Importantly, this study demonstrates that blocking TIGIT can reverse T cell exhaustion and restore function in patients with chronic HBV infection. CONCLUSIONS: HBV induces T cell exhaustion by up-regulating the expression of TIGIT. Blocking the TIGIT/PVR signaling pathway can reverse T cell exhaustion, so this discovery provides an immunotherapy target to battle chronic HBV infection. AJTR
Authors: Sian M Henson; Ornella Franzese; Richard Macaulay; Valentina Libri; Rita I Azevedo; Sorena Kiani-Alikhan; Fiona J Plunkett; Joanne E Masters; Sarah Jackson; Stephen J Griffiths; Hans-Peter Pircher; Maria V D Soares; Arne N Akbar Journal: Blood Date: 2009-04-30 Impact factor: 22.113
Authors: Steven D Levin; David W Taft; Cameron S Brandt; Christoph Bucher; Edward D Howard; Eric M Chadwick; Janet Johnston; Angela Hammond; Kristen Bontadelli; Daniel Ardourel; LuAnn Hebb; Anitra Wolf; Thomas R Bukowski; Mark W Rixon; Joseph L Kuijper; Craig D Ostrander; James W West; Janine Bilsborough; Brian Fox; Zeren Gao; Wenfeng Xu; Fred Ramsdell; Bruce R Blazar; Katherine E Lewis Journal: Eur J Immunol Date: 2011-03-18 Impact factor: 5.532
Authors: Patrick T F Kennedy; Elena Sandalova; Juandy Jo; Upkar Gill; Ines Ushiro-Lumb; Anthony T Tan; Sandhia Naik; Graham R Foster; Antonio Bertoletti Journal: Gastroenterology Date: 2012-06-15 Impact factor: 22.682
Authors: Liliana E Lucca; Pierre-Paul Axisa; Emily R Singer; Neal M Nolan; Margarita Dominguez-Villar; David A Hafler Journal: JCI Insight Date: 2019-02-07
Authors: Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones Journal: Nat Med Date: 2002-04 Impact factor: 53.440
Authors: Carmen Stecher; Claire Battin; Judith Leitner; Markus Zettl; Katharina Grabmeier-Pfistershammer; Christoph Höller; Gerhard J Zlabinger; Peter Steinberger Journal: Front Immunol Date: 2017-05-22 Impact factor: 7.561